ETFs such as The Schwab US Dividend ETF can be useful, but a 'DIY' approach can help you outperform. Here are 3 of the best ...

We are bullish on Dave & Buster's turnaround plan and potential stock price surge of over 50% within 1-2 years. Read an ...

Janus Henderson's second quarter report shows potential for growth, but acquisition risks and valuation concerns may warrant ...

The Fund returned 8.79% versus 7.76% for the MSCI World ex USA Index for the quarter, and 8.55% since inception, versus 6.22% ...

The Fund returned 11.90% versus 10.45% for the MSCI World ex USA Small Cap Index (net) for the quarter. Since its inception ...

Discover why I'm not yet sold on MODL's strategy, and believe the potential advantages it offers is offset by its 0.46% ...

Yancoal Australia is upgraded to a Buy, citing positive growth outlook, dividend omission signal, and attractive valuations.

Immatics, a biotech company working on promising cell-based immunotherapies for solid cancers, has a promising TCR-engineered ...

Financial writer recommends buying Rubrik stock with a $48 target, citing strong growth and high customer expansion rates.

Discover more on Sitio Royalties' production growth and guidance, emphasizing share repurchases over dividends and potential ...

Talen Energy stock fell after PJM Interconnection delays capacity auction by around six months to give it time to address a ...

Crude oil futures fell slightly on Friday but posted their second straight weekly gain in volatile trading marked by ...